CITEX | RITHX | CITEX / RITHX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 23 years | 9 years | - |
Gain YTD | 8.772 | 9.184 | 96% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 250 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 22.5B | 22.5B | 100% |
Annual Yield % from dividends | 6.23 | 6.67 | 93% |
Returns for 1 year | 14.93 | 15.46 | 97% |
Returns for 3 years | 10.98 | 12.51 | 88% |
Returns for 5 years | 31.22 | 34.22 | 91% |
Returns for 10 years | 56.04 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
TRULX | 44.89 | -0.28 | -0.62% |
T. Rowe Price US Large-Cap Core | |||
NGDRX | 29.78 | -0.19 | -0.63% |
Neuberger Berman Large Cap Growth R3 | |||
CMPCX | 22.44 | -0.19 | -0.84% |
Calvert Small/Mid-Cap C | |||
HULIX | 33.73 | -0.49 | -1.43% |
Huber Select Large Cap Value Inv | |||
FBDIX | 143.59 | -3.22 | -2.19% |
Franklin Biotechnology Discovery A |